Last reviewed · How we verify
Placebo to match danazol
Placebo to match danazol is a Small molecule drug developed by Sierra Oncology LLC - a GSK company. It is currently in Phase 3 development for Control arm in phase 3 clinical trial comparing danazol efficacy.
This is a placebo formulation designed to match the appearance and administration of danazol for use as a control in clinical trials.
This is a placebo formulation designed to match the appearance and administration of danazol for use as a control in clinical trials. Used for Control arm in phase 3 clinical trial comparing danazol efficacy.
At a glance
| Generic name | Placebo to match danazol |
|---|---|
| Sponsor | Sierra Oncology LLC - a GSK company |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
Placebo-to-match formulations are inert preparations engineered to be indistinguishable from the active drug in terms of appearance, taste, smell, and packaging to maintain blinding in randomized controlled trials. In this case, the placebo is formulated to match danazol, an androgenic steroid, allowing researchers to compare the efficacy and safety of danazol against an inactive control while preventing bias from participants or investigators knowing treatment assignment.
Approved indications
- Control arm in phase 3 clinical trial comparing danazol efficacy
Common side effects
Key clinical trials
- The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis (PHASE2)
- A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo to match danazol CI brief — competitive landscape report
- Placebo to match danazol updates RSS · CI watch RSS
- Sierra Oncology LLC - a GSK company portfolio CI
Frequently asked questions about Placebo to match danazol
What is Placebo to match danazol?
How does Placebo to match danazol work?
What is Placebo to match danazol used for?
Who makes Placebo to match danazol?
What development phase is Placebo to match danazol in?
Related
- Manufacturer: Sierra Oncology LLC - a GSK company — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Control arm in phase 3 clinical trial comparing danazol efficacy